SL Science Holding SLBT
NASDAQ SLBT
$0.94 +0.04 (+4.44%)
At close: Nov 6, 2026 · 4:00 PM EST

SL Science Holding (SLBT) Change in Accrued Expenses (2025 - 2026)

Updated

SL Science Holding (SLBT) recorded Change in Accrued Expenses of -$317,727 in Q2 2026, compared with $145,030 a year earlier.

Analysis

SL Science Holding (SLBT) Change in Accrued Expenses (2025 - 2026) Analysis & Trends

For FY2025, SL Science Holding reported Change in Accrued Expenses of $246,726, up 538.9% from FY2024.

  • Across earlier years, Change in Accrued Expenses came in at $38,620 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 2.41 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 983.00 Mn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 SL Science Holding 1.98 Bn 1.96 Bn - -317,727.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -317,727.00
Mar 31, 2026 200,705.00
Jun 30, 2025 145,030.00
API Access

SL Science Holding Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SLBT&period=max&api_key=YOUR_API_KEY